Article Sidebar

PDF
Published: 2021-12-31
Abstract Views: 205
Views PDF: 144
DOI: https://doi.org/10.52852/tcncyh.v148i12.773
Issue
Vol. 148 No. 12 (2021): Tập 148 số 12 E9
Section
Các bài báo
How to Cite
Van Anh, P. T. ., Dam, N. V. ., Ky, P. T. ., Hang, V. V. ., & Hang, D. T. T. . (2021). The study of acute and subchronic toxicities of Da Dai Trang HVD capsules in experimental animals. Journal of Medical Research, 148(12), 7-15. https://doi.org/10.52852/tcncyh.v148i12.773

The study of acute and subchronic toxicities of Da Dai Trang HVD capsules in experimental animals

Pham Thi Van Anh, Nguyen Van Dam, Pham Thanh Ky, Vu Viet Hang, Dinh Thi Thu Hang

Main Article Content

Abstract

The purpose of this research is to evaluate the acute and subchronic toxicities of DA DAI TRANG HVD capsules through oral administration in experimental animals. The acute toxicity was determined by the method of Litchfield Wilcoxon in Swiss mice. The subchronic toxicity was evaluated by the recommendation of WHO and OECD in Wistar rats with oral doses of 1.44 g/kg/day (equal to recommended human dose) and 4.32 g/kg/day (3 times as high as recommended human dose) in 4 consecutive weeks. As a result, DA DAI TRANG HVD capsules at the highest dose used for mice (99.9 g materials/kg) did not express acute toxicity in mice. In term of the subchonic toxicity test, DA DAI TRANG HVD had no deleterious effect on hematological parameters, hepato-renal functions, macroscopic and microscopic images of livers and kidneys of rats. In conclusion, DA DAI TRANG HVD capsules did not produce the acute and subchronic toxicities in Swiss mice and Wistar rats.

Article Details

Keywords

DA DAI TRANG HVD capsules, acute toxicity, subchronic toxicity, experimental animals

References

1. Guite NT. International Protocol and Indigenous Knowledge on Medicine and Health Care: An overview. The Asian Man. 2010;1(4):01-12.
2. World Health Organization. Global report on traditional and complementary medicine. 2019.
3. Venkatasubbu GD, Ramasamy S, Gaddam PR, et al. Acute and subchronic toxicity analysis of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. International Journal of Nanomedicine. 2015;10:137-148.
4. De Jong WH, Carraway JW, Geertsma RE. In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. Biocompatibility and Performance of Medical Devices. 2012;120-158.
5. SAGANUWAN SA. Toxicity studies of drugs and chemicals in animals: an overview. Bulgarian Journal of Veterinary Medicine. 2017;4(20):291-318.
6. OECD. Guidelines for the testing of chemicals repeated dose oral toxicity study in rodents. Environmental Health and Safety Monograph Series on Testing and Assesment No 407; 2008.
7. World Health Organization. Guidelines for Assessing Quality of Herbal Medicines With Reference to Contaminants and Residues. World Health Organization, Geneva; 2007.
8. Litchfield J T& Wilcoxon F A. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949;96:99-113.
9. Venkatasubbu GD. Ramasamy S. Gaddam PR. et al. Acute and subchronic toxicity analysis of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. International Journal of Nanomedicine. 2015;10:137-148.
10. World Health Organization. Working group on the safety and efficacy of herbal medicine. Report of regional office for the western pacific of the World Health Organization. 2000.
11. Lee M, Seo C, Cha S, et al. Safety assessment of So-cheong-ryong-tang: subchronic toxicity study in Crl: CD Sprague Dawley rats. Mol Med Rep. 2014;9:2273-2282.
12. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regulatory Toxicology and Pharmacology. 2000;32(1):56-67.
13. Kunanusorn P, Panthong A, Pittayanurak P et al. Acute and subchronic oral toxicity studies of Nelumbo nucifera stamens extract in rats. J Ethnopharmacol. 2011;134(3):789-95.